Showing results (31-40 of 41) with videos related to

Sort By:
Pageof 5
Japanese Journal of Ophthalmology|July 27, 2016
Radiating hemorrhage in exudative age-related macular degenerationJae Hui Kim, Young Suk Chang, Jong Woo Kim, et al.
Retina (Philadelphia, Pa.)|July 7, 2018
LONG-TERM VISUAL CHANGES IN INITIALLY STRONGER FELLOW EYES IN PATIENTS WITH UNILATERAL TYPE 3 NEOVASCULARIZATIONJae Hui Kim, Young Suk Chang, Jong Woo Kim, et al.
Clinical & Experimental Optometry|February 16, 2016
Self-recognition of recurrences among patients with exudative age-related macular degenerationJae Hui Kim, Young Suk Chang, Jong Woo Kim, et al.
Graefe'S Archive for Clinical and Experimental Ophthalmology = Albrecht Von Graefes Archiv Fur Klinische Und Experimentelle Ophthalmologie|September 20, 2015
Polypoidal choroidal vasculopathy in patients aged less than 50 years: characteristics and 6-month treatment outcomeYoung Suk Chang, Jae Hui Kim, Jong Woo Kim, et al.
Korean Journal of Ophthalmology : KJO|May 5, 2017
Treatment of Bilateral Retinal Angiomatous Proliferation with Anti-vascular Endothelial Growth Factor: 12-Month OutcomeJae Min Kim, Jae Hui Kim, Young Suk Chang, et al.
Korean Journal of Ophthalmology : KJO|October 13, 2015
Clinical Outcomes of Eyes with Submacular Hemorrhage Secondary to Age-related Macular Degeneration Treated with Anti-vascular Endothelial Growth FactorKun Hae Kim, Jae Hui Kim, Young Suk Chang, et al.
Ophthalmology|December 18, 2013
Intravitreal anti-vascular endothelial growth factor for submacular hemorrhage from choroidal neovascularizationJae Hui Kim, Young Suk Chang, Jong Woo Kim, et al.
Journal of Ocular Pharmacology and Therapeutics : the Official Journal of the Association for Ocular Pharmacology and Therapeutics|March 19, 2016
Long-Term Outcomes of Anti-Vascular Endothelial Growth Factor Therapy for Polypoidal Choroidal VasculopathyYoung Suk Chang, Jae Hui Kim, Kyung Min Kim, et al.
Pageof 5